IPBronch.com | Interventional Pulmonology

JTD Oct 27, 2026

Admission-based scoring model for predicting in-hospital mortality in secondary spontaneous pneumothorax: a multicenter retrospective cohort study

Study Takeaway

Provides useful risk stratification tools for managing secondary spontaneous pneumothorax patients who often require IP intervention.

Authors not listed

IP Score: 6/10 View Analysis →

JTD Oct 27, 2026

Pleural infection-current diagnosis and management

Study Takeaway

Highlights core pleural management strategies crucial for interventional pulmonologists handling complicated parapneumonic effusions and empyema.

Authors not listed

IP Score: 8/10 View Analysis →

JTD Oct 27, 2026

Pneumothorax: from definition to diagnosis and treatment

Study Takeaway

Directly impacts IP practice regarding pleural interventions, chest tube insertion, and management of persistent air leaks.

Authors not listed

IP Score: 7/10 View Analysis →

JTD Oct 27, 2026

Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment

Study Takeaway

Relevant for IP specialists involved in the bronchoscopic and image-guided tissue diagnosis and staging of apical lung masses.

Authors not listed

IP Score: 6/10 View Analysis →

JTD Oct 27, 2026

Management of incidental lung nodules <8 mm in diameter

Study Takeaway

Relevant to IP practices managing pulmonary nodules discovered during staging or diagnostic workups.

Authors not listed

IP Score: 6/10 View Analysis →

ERJ_Open Oct 27, 2026

Heart failure-related pleural effusion: determinants of pleural drainage and predictors of mortality in a cohort of 1372 patients

Study Takeaway

Provides helpful clinical context on pleural drainage utilization in heart failure effusions, relevant to pleural disease management.

Authors not listed

IP Score: 6/10 View Analysis →

ERJ Oct 27, 2026

Treating the patient or the image? Interpreting treatment success in pleural infection

Study Takeaway

Clinicians managing pleural infections should integrate clinical response rather than relying solely on radiographic resolution to determine treatment success.

Authors not listed

IP Score: 7/10 View Analysis →

Lancet Oct 24, 2026

[Correspondence] Unanswered questions from the NIMBLE trial – Authors’ reply

Study Takeaway

Provides helpful clarification on interpreting recent bronchoscopic trial data relevant to interventional pulmonologists.

Tuan Vu, Rodrigo Pavani, NIMBLE investigators

IP Score: 6/10 View Analysis →

Chest Oct 23, 2026

Non-Diagnostic Does Not Mean Non-Malignant: Outcomes and Predictors of Malignancy Following Nondiagnostic Robotic-Assisted Bronchoscopy.

Study Takeaway

Provides valuable clinical data on managing nondiagnostic robotic bronchoscopy results to optimize lung cancer diagnosis.

Kim JJ; Phan C; Stocking JC; Lagana M; Sayal R; Nguyen B

IP Score: 8/10 View Analysis →

Chest Oct 22, 2026

Diagnostic Contribution of Endobronchial Optical Coherence Tomography in the Multidisciplinary Diagnosis of Interstitial Lung Disease.

Study Takeaway

BACKGROUND: Less-invasive, lower-risk alternatives to surgical lung biopsy (SLB) have emerged for interstitial lung disease (ILD) diagnosis, such as transbronchial lung cryobiopsy (TBLC) and Envisia Genomic Classifier (E…

Arao RK; Yamamoto S; Nandy S; Sharma A; Lee J; Berigei SR

IP Score: 10/10 View Analysis →

Lung Oct 22, 2026

Utility and Safety of a Novel Preoperative Marking via Ultrathin Bronchoscopy in Thoracic Surgery.

Study Takeaway

PURPOSE: Virtual-assisted lung mapping (VAL-MAP) is a safe and useful procedure for identifying suitable lines for sublobar lung resections. Nonetheless, the current VAL-MAP technique using a thin bronchoscope limits acc…

Kimura H; Ito T; Nakamura S; Kinoshita F; Baba T; Nakanishi K

IP Score: 10/10 View Analysis →

Thorax Oct 22, 2026

Guideline adherence to invasive mediastinal staging in contemporary resectable NSCLC trials: a systematic review.

Study Takeaway

Highlights the critical role of EBUS-TBNA and mediastinoscopy in clinical trial quality control and accurate lung cancer staging.

Contreras-Garza BM; Flores-Mejia J; Martinez-Valenciano JM; Sanchez-Soto C; Jimenez-Lopez J; Guzmán-Delgado NE

IP Score: 7/10 View Analysis →

Literature Archives